^
BIOMARKER:

PD-L1 overexpression + FGFR3 amplification

i
Other names: PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule, FGFR3, ACH, CD333, CEK2, JTK4, Fibroblast growth factor receptor 3
Entrez ID:
News
Twitter
Trials
PD-L1 overexpression + FGFR3 amplification
NSCLC
nivolumab
Resistant: C4 – Case Studies
Front Oncol - 1 week
PD-L1 overexpression + FGFR3 amplification
NSCLC
nivolumab + anlotinib
Sensitive: C4 – Case Studies
Front Oncol - 1 week